Drugs and Therapeutics (D & T) Committee Meeting Results* for: March 26, 2008
Drug Name | Review Type | Committee Recommendation | Prior Approval Status � Final Determination |
---|---|---|---|
Combigan | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Iquix | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Lipofen | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
ProAir HFA | PDL Appeal | Remain Non-Preferred | Non-Preferred � PDL Class |
Saizen | PDL Appeal | Remain Non-Preferred | Non-Preferred � PDL Class |
Sanctura XR | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Simcor | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Tekturna | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Vusion | New Drug Initial Review | Require Prior Approval | Prior Approval Required |